Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.
about
Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic reviewSystematic review of studies evaluating the broader economic impact of vaccination in low and middle income countriesPerformance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model.Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsLearning lessons from operational research in infectious diseases: can the same model be used for noncommunicable diseases in developing countries?Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov modelSystematic review of the cost-effectiveness of the vaccination against HPV in Brazil.Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation.Potential benefits of second-generation human papillomavirus vaccines.The use of cost-effectiveness analysis for pediatric immunization in developing countriesDynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.Colorimetric detection of human papilloma virus by double isothermal amplification.Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries.Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening.
P2860
Q28082953-E41A585A-502D-40FE-BD0D-4D624BDBB093Q28277203-7165DA0C-54A8-4A8D-9C50-E1687D946CCEQ33858092-7F982249-D0C0-4A6B-A221-522519A77528Q33898846-35557CDC-3AC4-44BE-B59F-478FBFF2E2C7Q33955841-38F33F5A-EAD6-4E1F-9C50-A1379226F12AQ34437088-F9DEDDB4-9799-49E5-B8C3-663AA5C36BA8Q34567701-ECF34E9F-EEA6-4752-AAE6-FFAB7ED15D3FQ34656807-B963593F-8EED-4D31-AD9A-18E9E96742D5Q34894228-5337A3FB-DC9D-41D3-B209-48BECDD0048AQ35886544-F2C0AFE1-ED14-4F98-AE40-2481BCB74F7EQ36183172-641E44A9-AA17-4E09-87EA-42D3712BBCBDQ36184620-0C3396EF-380D-4116-BF1F-E2C2ACA1DAA0Q36380862-0B26302D-CFFA-4E36-8B4B-91DAF42C9999Q36490234-0646A99C-C886-4653-B54B-1759709FEE38Q39550770-73B1931E-0679-483B-9EC8-EAA354620003Q42264464-1258FAE0-A35F-483B-8048-61EB61A76229Q48103667-2AE13B4F-221C-42C8-97ED-40B5BE4F5DE6Q55397815-254C36CD-6BA5-4419-88F8-E1573233F5ED
P2860
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@ast
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@en
type
label
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@ast
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@en
prefLabel
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@ast
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@en
P2093
P2860
P356
P1433
P1476
Human papillomavirus vaccine i ...... of cost-effectiveness models.
@en
P2093
Elamin Elbasha
Gary Ginsberg
Nadia Demarteau
Naiyana Praditsitthikorn
Raymond Hutubessy
P2860
P2888
P356
10.1186/1741-7015-9-54
P407
P577
2011-05-12T00:00:00Z
P5875
P6179
1049233578